Bruce C. Cozadd
2020
Compensation breakdown
| Non-Equity Incentive Plan | $1,381,400 |
|---|---|
| Option Awards | $4,210,661 |
| Salary | $1,085,123 |
| Stock Awards | $5,881,195 |
| Other | $14,921 |
| Total | $12,573,300 |
Cozadd received $5.9M in stock awards, accounting for 47% of the total pay in 2020.
Cozadd also received $1.4M in non-equity incentive plan, $4.2M in option awards, $1.1M in salary and $14.9K in other compensation.
Rankings
In 2020, Bruce C. Cozadd's compensation ranked 568th out of 13,090 executives tracked by ExecPay. In other words, Cozadd earned more than 95.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 568 out of 13,090 | 96th |
Division Manufacturing | 195 out of 5,621 | 97th |
Major group Chemicals And Allied Products | 64 out of 2,254 | 97th |
Industry group Drugs | 55 out of 1,954 | 97th |
Industry Pharmaceutical Preparations | 40 out of 1,459 | 97th |
Pay ratio
| Bruce C. Cozadd's Pay | $12,573,300 |
|---|---|
| Median Employee's Pay | $234,935 |
| Pay Ratio | 54to 1 |
In 2020, the annual total compensation of Bruce C. Cozadd was $12,573,300.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.
The ratio of Bruce C. Cozadd's pay to the pay of median employee was therefore 54 to one.
Cozadd's colleagues
We found five more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2020.
2020
Kim Sablich
Jazz Pharmaceuticals
Executive Vice President and General Manager, North America
2020
Daniel Swisher
Jazz Pharmaceuticals
Chief Operating Officer
2020
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
2020
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
2020
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
News
June 10, 2022
June 11, 2021
June 12, 2020
June 14, 2019